Symptomtext
patient was inadvertently administered an expired dose of the Adacel single-dose vial with no adverse event; Initial information was received on 29-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 11 years old female patient who experienced patient was inadvertently administered an expired dose of the adacel single-dose vial with no adverse event while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) and MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) for Immunisation. On 29-Jun-2022, the patient received 0.5 ml of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot U6702AA, expiry-20-JUN-2022) (formulation, and strength: unknown) via intramuscular route in unknown administration site for Immunization. On 29-JUN-2022 the patient developed a non-serious patient was inadvertently administered an expired dose of the adacel single-dose vial with no adverse event (expired product administered) (latency same day) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event patient was inadvertently administered an expired dose of the adacel single-dose vial with no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.